<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:hpo ids='HP_0011010'>chronic</z:hpo> inflammatory state in patients with <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> places them at a substantially elevated risk for developing colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Moreover, distinguishing an inflammatory phenotype from <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> can be difficult and has significant patient management implications </plain></SENT>
<SENT sid="2" pm="."><plain>To this end, we studied the expression of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cell marker <z:chebi fb="1" ids="17478">aldehyde</z:chebi> dehydrogenase to determine whether expression is increased in dysplastic lesions arising in <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>We studied 54 patients with <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> who underwent surgical resection </plain></SENT>
<SENT sid="4" pm="."><plain>Of the 54 patients, 13 exhibited high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, 19 exhibited low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, and 22 displayed only inflammatory atypia </plain></SENT>
<SENT sid="5" pm="."><plain>Staining for <z:chebi fb="1" ids="17478">aldehyde</z:chebi> dehydrogenase was evaluated in the cytoplasm of epithelial and stromal cells </plain></SENT>
<SENT sid="6" pm="."><plain>We determined the intensity of staining (0 to 3+) and the percentage of cells staining positively </plain></SENT>
<SENT sid="7" pm="."><plain>Positive staining for <z:chebi fb="1" ids="17478">aldehyde</z:chebi> dehydrogenase was observed in 92% (12/13) of cases with high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>/<z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and in 95% (18/19) of cases with low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>Cases with inflammatory atypia showed positive staining in 45% (10/22) of cases </plain></SENT>
<SENT sid="9" pm="."><plain>The sensitivity for <z:chebi fb="1" ids="17478">aldehyde</z:chebi> dehydrogenase in epithelial cells as a marker for <z:mpath ids='MPATH_589'>dysplasia</z:mpath> was 95%; specificity was 55% </plain></SENT>
<SENT sid="10" pm="."><plain>For stromal cells adjacent to <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, sensitivity was 44%; and specificity was 68% </plain></SENT>
<SENT sid="11" pm="."><plain>Although the sensitivity of <z:chebi fb="1" ids="17478">aldehyde</z:chebi> dehydrogenase for <z:mpath ids='MPATH_589'>dysplasia</z:mpath> was excellent, specificity was less than ideal </plain></SENT>
<SENT sid="12" pm="."><plain>Our findings support the hypothesis that <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> is associated with increased <z:chebi fb="1" ids="17478">aldehyde</z:chebi> dehydrogenase positivity, which supports the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cell hypothesis </plain></SENT>
</text></document>